Synmosa Biopharma Revenue

In the year 2024, Synmosa Biopharma had annual revenue of 5.55B TWD with 7.96% growth. Synmosa Biopharma had revenue of 1.51B in the quarter ending December 31, 2024, with 13.03% growth.

Revenue

5.55B

Revenue Growth

+7.96%

P/S Ratio

2.70

Revenue / Employee

n/a

Employees

n/a

Market Cap

15.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.55B	409.05M	7.96%
Dec 31, 2023	5.14B	754.13M	17.19%
Dec 31, 2022	4.39B	1.15B	35.59%
Dec 31, 2021	3.23B	196.67M	6.47%
Dec 31, 2020	3.04B	358.32M	13.37%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	11.34B
Caliway Biopharmaceuticals	40.47M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	19.12B
Polaris Group	107.00M
Oneness Biotech	117.93M
Pegavision	6.69B
Lumosa Therapeutics	43.59M

Revenue Rankings